SS
DTIL icon

Steve Schonfeld’s Precision BioSciences DTIL Stock Holding History

Steve Schonfeld’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,552
Closed -$223K – 2700
2026
Q1 		$223K Buy
+40,552
New +$187K ﹤0.01% 1696
2023
Q2 		– Sell
-343
Closed -$7.76K – 2222
2023
Q1 		$7.76K Sell
343
-657
-66% -$21.6K ﹤0.01% 1876
2022
Q4 		$35.7K Sell
1,000
-1,150
-53% -$45.4K ﹤0.01% 2285
2022
Q3 		$83K Sell
2,150
-442
-17% -$21K ﹤0.01% 2588
2022
Q2 		$124K Buy
2,592
+439
+20% +$25.8K ﹤0.01% 2075
2022
Q1 		$199K Buy
+2,153
New +$293K ﹤0.01% 1970
2021
Q3 		– Sell
-1,183
Closed -$444K – 2220
2021
Q2 		$444K Buy
1,183
+656
+124% +$197K ﹤0.01% 1254
2021
Q1 		$164K Buy
+527
New +$184K ﹤0.01% 1564

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Steve Schonfeld's DTIL Position: Q2 2026 in Review

Steve Schonfeld sold out of Precision BioSciences (DTIL) in Q2 2026, closing a stake of 40,552 shares — an estimated $223K sold.

Steve Schonfeld first reported a position in DTIL in Q1 2021 and held it in 8 quarters. The position peaked at $444K in Q2 2021. 94 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Steve Schonfeld reported no remaining Precision BioSciences position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 40,552 Precision BioSciences shares in Q2 2026, an estimated $223K.
  • Steve Schonfeld first reported a position in Precision BioSciences in Q1 2021 and held it in 8 quarters.
  • Steve Schonfeld's Precision BioSciences position peaked at $444K in Q2 2021.
  • 94 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.